Jill DeSimone
CIK 1930479 · last filed 2026-06-26
Jill DeSimone is a corporate insider who has filed 15 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing, for PRAX, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$3.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.75M
4
15
-$3.59M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRAX | Director | 4,957 | $353.44 | $1.75M | -$3.59M | 7 | 2026-06-26 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | — | $0.53 | — | $0 | 3 | 2024-06-24 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | — | $10.15 | — | $0 | 2 | 2024-06-13 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 1 | 2023-03-03 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | PRAX | Mixed | — | -$2.79M | EDGAR |
| 2026-06-24 | PRAX | Notice (144) | −11,600 | -$3.61M | EDGAR |
| 2026-06-12 | PRAX | Grant (A) | +1,371 | $0 | EDGAR |
| 2025-06-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2024-04-05 | — | Disp (D) | — | $0 | |
| 2024-03-07 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-10 | PRAX | Buy (P) | +14,500 | $25.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.